Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
Acasti Pharma(ACST) Newsfilter·2024-06-28 04:05Acasti Pharma(ACST) Newsfilter·2024-06-28 04:05
R1Acasti Pharma(ACST) Newsfilter·2024-06-28 04:05 R1Acasti Pharma(ACST) Newsfilter·2024-06-28 04:05